Klin Monbl Augenheilkd 2018; 235(04): 478-479
DOI: 10.1055/s-0043-121562
Der interessante Fall
Georg Thieme Verlag KG Stuttgart · New York

Toxoplasma gondii-Associated Bilateral Panuveitis and Encephalitis after Bone Marrow Transplantation

Toxoplasma-gondii-assoziierte beidseitige Panuveitis und Enzephalitis nach Knochenmarktransplantation
Anthia Papazoglou
Department of Ophthalmology, UniversityHospital Zurich, Zurich, Switzerland
,
Sandrine Zweifel
Department of Ophthalmology, UniversityHospital Zurich, Zurich, Switzerland
,
Daniel Barthelmes
Department of Ophthalmology, UniversityHospital Zurich, Zurich, Switzerland
,
Mayss Al-Sheikh
Department of Ophthalmology, UniversityHospital Zurich, Zurich, Switzerland
,
Christian Boeni
Department of Ophthalmology, UniversityHospital Zurich, Zurich, Switzerland
› Author Affiliations
Further Information

Publication History

received 19 September 2017

accepted 05 October 2017

Publication Date:
20 November 2017 (online)

Background

Toxoplasmosis is one of the most common causes of infectious retinitis in both immunocompetent and immunocompromised individuals [1]. Toxoplasmic chorioretinitis in immunocompetent patients can be diagnosed clinically due to its typical presentation as a monocular, focal, necrotizing chorioretinitis lesion, sometimes adjacent to an older pigmented chorioretinal scar. However, in immunocompromised patients the clinical appearances of ocular toxoplasma infection can vary widely and thus be diagnostically challenging [2].

We report a patient, who presented with systemic worsening and bilateral panuveitis resulting in blindness two years after successful bone-marrow transplantation. Diagnostic testing confirmed ocular toxoplasmosis and consecutively, toxoplasmosis-related encephalitis was diagnosed.

 
  • References

  • 1 Vallochi AL, Muccioli C, Martins MC. et al. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol 2005; 139: 350-361
  • 2 Moshfeghi DM, Dodds EM, Couto CA. et al. Diagnostic approaches to severe, atypical toxoplasmosis mimicking acute retinal necrosis. Ophthalmology 2004; 111: 716-725
  • 3 Ruskin J, Remington JS. Toxoplasmosis in the compromised host. Ann Int Med 1976; 84: 193-199
  • 4 Holland GN. Reconsidering the pathogenesis of ocular toxoplasmosis. Am J Ophthalmol 1999; 128: 502-505
  • 5 Holland GN, Engstrom RE, Glasgow BJ. et al. Ocular toxoplasmosis in patients with the acquired immunodeficiency syndrome. Am J Ophthalmol 1988; 106: 653-667
  • 6 Parke DW, Font RL. Diffuse toxoplasmic retinochoroiditis in a patient with AIDS. Arch Ophthalmol 1986; 104: 571-575
  • 7 Boyer DS. Discussion of paper by Holland et al. Acquired immunodeficiency syndrome; ocular manifestations. Ophthalmology 1983; 90: 872-873
  • 8 Basu S, Das T, Biswas G. Bilateral toxoplasma retinochoroiditis in patient with chronic myeloid leukemia treated with imatinib mesylate. Ocul Immunol Imflamm 2009; 18: 64-65
  • 9 Palkovacs EM, Correa Z, Augsburger JJ. et al. Acquired toxoplasmic retinitis in an immunosuppressed patient: diagnosis by transvitreal fine-needle aspiration biopsy. Graefes Arch Clin Exp Ophthalmol 2008; 246: 1495-1497
  • 10 Lau CH, Missotten T, Salzmann J. et al. Acute retinal necrosis features, management, and outcomes. Ophthalmology 2007; 114: 756-762